GRCE

#4009
Grace Therapeutics, Inc. - Common Stock
2.5 7 USD
+5.76%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.57
2.57
Year Range
0.02
5.18
Daily Change
+5.76%
Monthly Change
+22.38%
6 month change
-35.43%
Year Change
-35.43%
Previous Close
2.4 3
Open
2.5 7
Low
2.5 7
High
2.5 7
Volume
7
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 39.77 M
  • Employee 6
  • Founded 2002
  • CEO N/A
  • Website www.gracetx.com
  • Headquarter Delaware, United States
  • FIGI BBG001NMDXS6
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.89
Price to sales ratio
1 621.12